Amyloid-beta clearance in Alzheimer's disease

Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis a...

Full description

Saved in:
Bibliographic Details
Main Authors: Robert Marr, Eliezer Masliah
Format: Online
Language:English
Published: Frontiers Media SA 2021
Subjects:
Online Access:18589
Tags: Add Tag
No Tags, Be the first to tag this record!